MRMD MARIMED INC revenue, earnings and financials

For the quarter ended June 30, 2026, MARIMED INC reported revenue of $41.9M (up 6.1% from a year earlier), net income of −$3.59M and diluted EPS of −$0.01; over the last four quarters revenue was $164M and net income −$15.0M; for the fiscal year ended December 2025 revenue was $160M, up 1.3% on the year before.

MRMD annual revenue and earnings

• Fiscal year ended Dec 2025: revenue $160M, gross profit $57.9M, operating income −$2.82M, net income −$14.5M (margin -9.1%), EPS −$0.04
• Fiscal year ended Dec 2024: revenue $158M, gross profit $62.6M, operating income $2.61M, net income −$12.5M (margin -7.9%), EPS −$0.03
• Fiscal year ended Dec 2023: revenue $149M, gross profit $65.9M, operating income $14.4M, net income −$16.0M (margin -10.8%), EPS −$0.04
• Fiscal year ended Dec 2022: revenue $134M, gross profit $64.0M, operating income $20.4M, net income $13.5M (margin 10.0%), EPS $0.04
• Fiscal year ended Dec 2021: revenue $121M, gross profit $66.3M, operating income $26.9M, net income $7.23M (margin 5.9%), EPS $0.02

MRMD quarterly revenue and earnings

• Quarter ended Jun 30, 2026: revenue $41.9M (up 6.1% year over year), net income −$3.59M, EPS −$0.01
• Quarter ended Mar 31, 2026: revenue $39.5M (up 4.2% year over year), net income −$3.79M, EPS −$0.01
• Quarter ended Dec 31, 2025 (from the annual report): revenue $41.7M (up 7.5% year over year), net income −$4.63M, EPS −$0.02
• Quarter ended Sep 30, 2025: revenue $40.8M (up 0.4% year over year), net income −$2.95M, EPS −$0.01
• Quarter ended Jun 30, 2025: revenue $39.5M (down 2.3% year over year), net income −$1.39M, EPS $0.00
• Quarter ended Mar 31, 2025: revenue $37.9M (down 0.1% year over year), net income −$5.51M, EPS −$0.01
• Quarter ended Dec 31, 2024 (from the annual report): revenue $38.7M (down 0.4% year over year), net income −$8.51M, EPS −$0.03
• Quarter ended Sep 30, 2024: revenue $40.6M (up 4.6% year over year), net income −$1.01M, EPS $0.00
• Quarter ended Jun 30, 2024: revenue $40.4M (up 10.7% year over year), net income −$1.65M, EPS $0.00
• Quarter ended Mar 31, 2024: revenue $37.9M (up 10.3% year over year), net income −$1.30M, EPS $0.00
• Quarter ended Dec 31, 2023 (from the annual report): revenue $38.9M (up 8.6% year over year), net income −$10.2M, EPS −$0.03
• Quarter ended Sep 30, 2023: revenue $38.8M (up 14.4% year over year), net income −$4.26M, EPS −$0.01
• Quarter ended Jun 30, 2023: revenue $36.5M (up 10.7% year over year), net income −$958K, EPS $0.00
• Quarter ended Mar 31, 2023: revenue $34.4M (up 9.9% year over year), net income −$645K, EPS $0.00
• Quarter ended Dec 31, 2022 (from the annual report): revenue $35.8M (up 15.4% year over year), net income $4.75M, EPS $0.02
• Quarter ended Sep 30, 2022: revenue $33.9M (up 2.1% year over year), net income $2.71M, EPS $0.01
• Quarter ended Jun 30, 2022: revenue $33.0M (up 1.3% year over year), net income $1.82M, EPS $0.00
• Quarter ended Mar 31, 2022: revenue $31.3M (up 26.9% year over year), net income $4.19M, EPS $0.01
• Quarter ended Dec 31, 2021 (from the annual report): revenue $31.0M, net income −$6.51M, EPS −$0.02
• Quarter ended Sep 30, 2021: revenue $33.2M, net income $2.02M, EPS $0.01

MRMD cash flow, buybacks and dividends

• Fiscal year ended Dec 2025: operating cash flow $7.70M, share buybacks n/a
• Fiscal year ended Dec 2024: operating cash flow $6.79M, share buybacks n/a
• Fiscal year ended Dec 2023: operating cash flow $7.91M, share buybacks n/a
• Fiscal year ended Dec 2022: operating cash flow $7.31M, share buybacks n/a
• Fiscal year ended Dec 2021: operating cash flow $35.9M, share buybacks n/a

MRMD balance sheet

• Jun 30, 2026: cash n/a, total assets $197M, total liabilities $147M, shareholders' equity n/a
• Mar 31, 2026: cash n/a, total assets $201M, total liabilities $148M, shareholders' equity n/a
• Dec 31, 2025: cash n/a, total assets $203M, total liabilities $138M, shareholders' equity n/a
• Sep 30, 2025: cash $6.60M, total assets $206M, total liabilities $137M, shareholders' equity n/a
• Jun 30, 2025: cash $6.14M, total assets $204M, total liabilities $131M, shareholders' equity n/a
• Mar 31, 2025: cash $7.20M, total assets $208M, total liabilities $134M, shareholders' equity n/a
• Dec 31, 2024: cash $7.28M, total assets $207M, total liabilities $129M, shareholders' equity n/a
• Sep 30, 2024: cash $9.79M, total assets $213M, total liabilities $126M, shareholders' equity n/a

What is MRMD's revenue?

MARIMED INC reported $164M of revenue over its last four quarters, through June 30, 2026.

Is MRMD profitable?

No. MARIMED INC lost $15.0M over the last four quarters.

What is MRMD's EPS?

Diluted earnings per share over the last four quarters were −$0.05; −$0.01 in the latest quarter.

MRMD ownership and insider trades · All stocks